Cardiovascular disease is the leading cause of death and has dramatically increased in
recent years. Continuous cardiac monitoring is particularly important for early diagnosis and …

Mesenchymal stem cells (MSCs) are one of a few stem cell types to be applied in clinical
practice as therapeutic agents for immunomodulation and ischemic tissue repair. In addition …

Despite improvements in interventional and pharmacological therapy of atherosclerotic
disease, it is still the leading cause of death in the developed world. Hence, there is a need …

Background—Despite rapid clinical translation and widespread enthusiasm, the therapeutic
benefits of adult bone marrow cell (BMC) transplantation in patients with ischemic heart …

Recent studies suggest that the therapeutic effects of stem cell transplantation following
myocardial infarction (MI) are mediated by paracrine factors. One of the main goals in the …

Coronary artery disease (CAD) is one of the most common causes of death worldwide. In the
last decade, significant advancements in CAD treatment have been made. The existing …

Humans and other mammals have three main adipose tissue depots: visceral white adipose
tissue, subcutaneous white adipose tissue and brown adipose tissue, each of which …

Rationale: CD34+ transplantation in dilated cardiomyopathy was associated with short-term
improvement in left ventricular ejection fraction and exercise tolerance. Objective: We …

Heart failure is a frequent complication of myocardial infarction. Several factors, such as
recurrent myocardial ischemia, infarct size, ventricular remodeling, stunned myocardium …

The therapeutic effects of stem cell transplantation in ischemic disease are mediated by the
production of paracrine bioactive factors. However, the bioactive factors secreted by human …